Inhibitor Therapeutics (INTI) Shares Outstanding (Entity) (2012 - 2026)
Inhibitor Therapeutics (INTI) Shares Outstanding (Entity) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.35 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.54 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 399.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 113.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.73 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 252.88 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 218.28 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 575.47 Mn |
| 10 | Inhibitor Therapeutics | 15.64 Mn | 15.64 Mn | - | 173.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 172.57 Mn |
| Dec 31, 2025 | 172.57 Mn |
| Sep 30, 2025 | 172.57 Mn |
| Jun 30, 2025 | 172.57 Mn |
| Mar 31, 2025 | 172.32 Mn |
| Dec 31, 2024 | 172.32 Mn |
| Sep 30, 2024 | 172.32 Mn |
| Jun 30, 2024 | 172.32 Mn |
| Mar 31, 2024 | 172.32 Mn |
| Dec 31, 2023 | 172.02 Mn |
| Sep 30, 2023 | 172.02 Mn |
| Jun 30, 2023 | 171.97 Mn |
| Mar 31, 2023 | 171.79 Mn |
| Dec 31, 2022 | 366.18 Mn |
| Sep 30, 2022 | 376.86 Mn |
| Jun 30, 2022 | 376.86 Mn |
| Mar 31, 2022 | 376.86 Mn |
| Dec 31, 2021 | 376.86 Mn |
| Sep 30, 2021 | 376.86 Mn |
| Jun 30, 2021 | 375.88 Mn |